The article also touches on the topics of osteopenia, sarcopenia, and medication-related osteonecrosis of the jaw (MRONJ), providing insights into diagnosis, treatment, and prevention. The document includes a comprehensive list of references for further research on osteoporosis and its treatmen...
Beginning with clear descriptions of the pathogenesis of osteoporosis and secondary osteoporosis, and the development of fractures, the book emphasizes the importance of prevention as well as treatment of this disease. There is a chapter on the beneficial effects of good nutrition and exercise on ...
including appropriate interpretation of bone densitometry and absolute fracture risk, thresholds for treatment, and interventions that can be used therapeutically together with their health economic evaluation.
(5) the joint(s) studied; (6) the cell type studied; (7) the drug studied; (8) drug route of administration, dosage, frequency, and treatment length; (9) methods of outcome assessment before and after treatment; (10) results/outcomes; and (11) association between treatment and results...
[Postmenopausal osteoporosis: general practitioners' application of the risk factors in the AFSSAPS guidelines. Survey of 2658 general practitioners ]. OBJECTIVES: Although AFSSAPS has set forth the recommended treatment strategies for postmenopausal osteoporosis, little is known about how this disorder is....
(IOF) brought worldwide attention to a crucial issue: the urgent need for robust osteoporosis screening and sustained care strategies to prevent fragility fractures. Under the theme “Say No to Fragile Bones,” it highlighted the gaps in diagnosis and treatment, stressing the ...
According to new guidelines set by the National Osteoporosis Foundation, post−menopausal women over 50 aren't the only people doctors need to monitor for the prevention and treatment of osteoporosis.Men over 50 and post−menopausal African−American, Asian, and Latina women also need to have...
To investigate the effects of prior treatment and determine the predictors of a 12-month treatment response of romosozumab (ROMO) in 148 patients with postmenopausal osteoporosis. Methods In this prospective, observational, and multicenter study, treatment naïve patients (Naïve; n = 50) or pat...
Currently, the sex of the patient, an important factor in the prevention, screening, and treatment of osteoporosis and fractures, has not been well taken into account. Most medications, guidelines, screening, and fracture risk prediction methods have been developed for women and subsequently adapted...
Currently, most treatment guidelines for osteoporosis are based on BMD from a central DXA [7]. The United States Preventive Services Task Force (USPSTF) currently does not recommend one specific screening test. The USPSTF, however, does recommend screening for osteoporosis with bone measurement ...